Article Per Year (5 Year)
p-Index From 2021 - 2026
7.255
P-Index
This Author published in this journals
All Journal Jurnal Ilmiah Farmasi Jurnal Farmasi Sains dan Komunitas Dinamisia: Jurnal Pengabdian Kepada Masyarakat JSFK (Jurnal Sains Farmasi & Klinis) Jurnal Ilmu Kefarmasian Indonesia Journal Syifa Sciences and Clinical Research (JSSCR) Pharmacoscript Jurnal Farmamedika (Pharmamedica Journal) Best Journal (Biology Education, Sains and Technology) Science Midwifery Jurnal Farmagazine Journal of Pharmaceutical and Health Research Journal of Holistic and Health Sciences (Jurnal Ilmu Holistik dan Kesehatan) Journal of Experimental and Clinical Pharmacy (JECP) Jurnal IPTEK Bagi Masyarakat Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Medical Sains : Jurnal Ilmiah Kefarmasian Jurnal Abdi Masyarakat Kita Jurnal Farmasi Sains dan Praktis Sciences of Pharmacy Journal of Global Pharma Technology Jurnal Pengabdian Pada Masyarakat Jurnal Farmasi Indonesia Jurnal Ilmiah Kesehatan Delima Parapemikir Jurnal Ilmiah Farmasi Borneo Journal of Pharmacy Medical Sains : Jurnal Ilmiah Kefarmasian Jurnal Farmasi Galenika Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan
Yusransyah, Yusransyah
Program Studi Farmasi Sekolah Tinggi Ilmu Kesehatan Salsabila Serang, Banten
Religion Aerospace Engineering Agriculture, Biological Sciences & Forestry Arts Humanities Astronomy Automotive Engineering Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Dentistry Earth & Planetary Sciences Economics, Econometrics & Finance Education Electrical & Electronics Engineering Energy Engineering Environmental Science Health Professions Immunology & microbiology Industrial & Manufacturing Engineering Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Library & Information Science Materials Science & Nanotechnology Mathematics Mechanical Engineering Medicine & Pharmacology Neuroscience Nursing Physics Public Health Social Sciences Transportation Veterinary Other

Published : 59 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 59 Documents
Search

 2   3   4   5   6 
PENGARUH PELATIHAN FARMASI KLINIK TERHADAP PENINGKATAN KOMPETENSI APOTEKER DI PUSKESMAS PROVINSI BANTEN DI ERA PANDEMI COVID-19 Yusransyah; Ahmad Sofan; Tuty Sriwahyuni; Lydya Elfira Sari Nasution; Raiyan
Jurnal Ilmiah Manuntung: Sains Farmasi Dan Kesehatan Vol. 8 No. 1 (2022): Jurnal Ilmiah Manuntung: Sains Farmasi Dan Kesehatan
Publisher : Sekolah Tinggi Ilmu Kesehatan Samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51352/jim.v8i1.497

Abstract

Latar belakang: Pelayanan kefarmasian oleh apoteker puskesmas di provinsi Banten belum optimal. Hal ini terlihat dari jumlah penggunaan obat antihipertensi dan prevalensi penyakit hipertensi yang meningkat dari tahun ke tahun serta menjadi salah satu penyebab kematian terbesar di provinsi Banten untuk kategori penyakit tidak menular. Hal ini menuntut apoteker untuk lebih mengoptimalkan peran mereka dengan meningkatkan kompetensi melalui pelatihan. Tujuan: Penelitian ini bertujuan untuk menilai tingkat pengetahuan dan kemampuan apoteker di puskesmas provinsi Banten dan untuk mengetahui apakah terdapat pengaruh yang signifikan sebelum dan sesudah pelatihan farmasi klinik bagi apoteker di puskesmas. Metode: Penelitian ini merupakan penelitian pra-eksperimen dengan desain satu grup yang diberikan pretest dan posttest. Pelatihan mencakup dua topik utama. Topik pertama tentang communication skill dan topik kedua tentang terapi anti hipertensi, dengan berbagai studi kasus di puskesmas. Hasil: Hasil penelitian ini menunjukkan bahwa skor rata-rata setelah pelatihan adalah 71,64 lebih tinggi dari skor sebelum pelatihan yaitu 51,23. Sebanyak 72 apoteker (dari total 73 apoteker) memiliki nilai skor setelah pelatihan yang lebih besar daripada sebelum pelatihan. Nilai konseling peserta pelatihan memang belum memenuhi standar, namun para apoteker peserta pelatihan mendapatkan pengalaman dan teknik konseling yang baik bagi pasien hipertensi di Puskesmas, yang bisa diimplementasikan di tempat kerja masing-masing. Kesimpulan: Pelatihan secara daring di era pandemi terbukti dapat meningkatkan pengetahuan dan kemampuan apoteker dalam memberikan pelayanan kefarmasian tentang anti hipertensi di puskesmas provinsi Banten yang dinilai dari hasil tes sebelum dan setelah pelatihan. Kata Kunci: Antihipertensi, Pelatihan Farmasi Klinik, Tingkat Pengetahuan, Apoteker Puskesmas
The Effect of Directly Observed Treatment Strategy on Cost Utility of Pulmonary Tuberculosis Patients at Banten Regional Public Hospital Udin, Baha; Yusransyah, Yusransyah; Saepudin, Saepudin
Borneo Journal of Pharmacy Vol. 8 No. 1 (2025): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v8i1.8601

Abstract

Pulmonary tuberculosis (TB) is one of the communicable diseases with high prevalence in some provinces in Indonesia, including the Province of Banten. Considering its high prevalence and the high cost of treatment resulting from multiple treatment components, research on the analysis of treatment costs of TB is very important. This study aimed to determine the effect of implementing the directly observed treatment (DOT) strategy on the cost-utility of pulmonary TB patients. The study was conducted at Banten Regional General Hospital using the perspective of the health provider and patients by involving 24 TB patients. Treatment cost was calculated by including direct medical costs, direct non-medical costs, and indirect costs, and then categorized into initial and final cost-utility. The average cost-effectiveness ratio (ACER) was then calculated by setting the patient's quality of life as the clinical outcome in this study. This study found that the average value of the average cost-utility ratio (ACUR) for the initial cost-utility and the final cost-utility were IDR 2,682,343.53 and IDR 2,402,153.15, respectively, and the difference was statistically significant (p=0.006). It indicates that the DOT strategy can potentially improve the utility costs of the treatment of TB patients at Banten Regional Hospital.
EVALUASI IMPLEMENTASI PELAYANAN KEFARMASIAN PADA PUSKESMAS DI KABUPATEN PANDEGLANG TAHUN 2024 Yusransyah, Yusransyah; Stiani, Sofi Nurmay; Nasiti, Febriane Dwi; Kelutur, Faruk Jayanto; Udin, Baha
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 10 No 1 (2025): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v10i1.2389

Abstract

Pharmaceutical services are considered by some observers to be below standard. Both pharmacists and pharmaceutical technicians as health technicians are required to improve their skills, knowledge and behavior in order to provide quality direct services to patients. The purpose of this study was to determine the implementation of pharmaceutical services at Health Centers in Pandeglang Regency in 2023. This study is an observational study with a case study design. The method used is descriptive using checklist sheets and open statements. Based on the results of this study, there are significant differences in the aspects of facilities and infrastructure and clinical pharmacy services and there are differences but not significant in the aspects of managing pharmaceutical preparations and disposable medical materials. The conclusion of this study is that pharmaceutical services at Health Centers in Pandeglang Regency are in accordance with Permenkes No. 74 of 2016 by obtaining a percentage value of 79%, entering the GOOD category.
ANALISIS EFEKTIVITAS BIAYA PASIEN COVID-19 MENGGUNAKAN TERAPI OKSIGEN DAN REMDESIVIR DI RSUD KABUPATEN TANGERANG Yusransyah, Yusransyah; Udin, Baha; Abdillah , Mursyid; Murdianto, Yudi; Soraya Uli, Elisabeth; Suryana, Nana
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 14 No. 1 (2022): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (419.714 KB) | DOI: 10.35617/jfionline.v14i1.75

Abstract

COVID-19 is a contagious disease, so there is a potential for an increase in the number of COVID-19 cases. If there is an increase in incidence or prevalence, it will cause problems related to the costs and outcomes of an intervention. Therefore, a cost-effectiveness analysis is needed. This study aims to determine the cost-effectiveness of COVID-19 patients who use oxygen therapy with and without being given remdesivir. This study uses a cost-effectiveness analysis method that takes into account the ACER (Average Cost-Effectiveness Ratio) and ICER (Incremental Cost-Effectiveness Ratio) values. The data used is retrospective data and sampling is done by purposive sampling, the sample obtained in this study amounted to 34 cases. The results of this study showed that the total average direct medical costs of the remdesivir group were Rp. 32,399,532 with an effectiveness of 47%, while in the non-remdesivir group the total average direct medical costs were Rp. 26,853,729 with an effectiveness of 41%. The ACER value obtained in this study was Rp. 688,490 in the remdesivir group and Rp. 654,969 in the non-remdesivir group. The results of the ICER calculation in this study were Rp. 924,301 per day of hospitalization. In this study, it can be concluded that the therapy group of COVID-19 patients who use oxygen therapy without being given remdesivir is more cost-effective than the therapy group of COVID-19 patients who use oxygen therapy with remdesivir.
ANALISIS TERAPI ANEMIA PADA PASIEN GAGAL GINJAL KRONIK DI RSUD Dr. DRADJAT PRAWIRANEGARA TAHUN 2022 Insani, Nurul; Zulfiani, Nia; Yusransyah, Yusransyah
Parapemikir : Jurnal Ilmiah Farmasi Vol 13, No 1 (2024): Parapemikir : Jurnal Ilmiah Farmasi
Publisher : Pusat Penelitian dan Pengabdian Masyarakat Politeknik Harapan Bersama

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30591/pjif.v13i1.5634

Abstract

AbstractUnder normal circumstances, 90% of the kidneys produce the hormone erythropoietin which has the function of stimulating the spinal cord to produce red blood cells, so that when kidney function decreases, there is a decrease in the production of the hormone erythropoietin which causes the formation of erythrocytes to be disrupted, resulting in a decrease in hemoglobin levels or anemia. The aim of this study was to determine the therapy of anemia in patients with chronic kidney failure undergoing hemodialysis and to determine the results of anemia therapy in patients with chronic renal failure undergoing hemodialysis at RSUD Dr. Dradjat Prawiranegara Year 2022. The research was conducted using a retrospective descriptive method by looking at the medical record data of chronic kidney failure patients undergoing hemodialysis who were receiving anemia therapy. The sample in this study amounted to 80 patients. The data were then analyzed descriptively regarding the analysis of anemia therapy in hemodialysis chronic kidney failure patients. The results showed that the hemodialysis hemoglobin level examination found an average of 8.8 g/dL and was included in the range below the normal value of hemoglobin levels. The most use of anemia drug therapy in 2022 for mono therapy is the most PRC Transfusion of 1 mg Folic Acid combination in 39 patients (48.8%). Furthermore, in the combination therapy of anemia with Blood Supplementary Tablets combined with Folic Acid 1 mg in 17 patients (21.3%) and the use of folic acid 1 mg in 24 patients (30.0%).Keywords:  Anemia, Chronic Kidney Failure, Hemodialysis, RSUD Dr. Dradjat Prawiranegara.
Peran Apoteker dalam Kepatuhan Penggunaan Tablet Tambah Darah untuk Pencegahan Stunting pada Siswi Pelita Cibitung Yusransyah, Yusransyah; Alfarizqi, Asep Salman; Sudarto, Teguh; Kholifah, Eva; Stiani, Sofi Nurmay; Udin, Baha
Jurnal IPTEK Bagi Masyarakat Vol 4 No 3 (2025)
Publisher : Ali Institute of Research and Publication

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55537/j-ibm.v4i3.1114

Abstract

Anemia in adolescent girls is a significant health issue in Indonesia, with high prevalence and long-term impacts on reproductive health, as well as an increased risk of stunting in their offspring. The Iron Supplementation (TTD) program has been initiated by the government as a stunting prevention effort, yet adherence to TTD consumption among adolescent girls remains low. The role of pharmacists as educators and facilitators in public health programs is crucial in improving TTD consumption adherence. This community service aims to improve adherence to TTD consumption as a stunting prevention measure among female vocational school students through the Anti-Stunting Movement Program at Pelita Cibitung Vocational School in 2024. Activities conducted include interactive education on stunting, anemia, and the importance of TTD consumption, as well as monitoring and evaluating TTD consumption adherence. Evaluation was performed using the Medication Adherence Report Scale (MARS) questionnaire. The evaluation results showed an increase in TTD consumption adherence after education and monitoring through WhatsApp Group. This demonstrates that the active involvement of pharmacists in education and monitoring can improve adherence to TTD consumption in adolescent girls.
Effectiveness of TB-Reminder Application in Improving Medication Adherence and Quality of Life of Lung Tuberculosis Patients in Indonesia Yusransyah, Yusransyah; Stiani, Sofi Nurmay; Chairani, Farahdina; Adini, Syilvi; Subchan, Mohamad; Ferdiyansyah, Ferdiyansyah; Putri, Nabila Septiani; Pratiwi, Rossi; Udin, Baha
Sciences of Pharmacy Volume 4 Issue 3
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0403358

Abstract

Poor adherence to anti-tuberculosis (TB) treatment continues to hinder therapeutic success and patient quality of life. This study aimed to evaluate the effectiveness of the TB-R mobile application in improving medication adherence and quality of life among pulmonary TB patients at Pandeglang Regional Hospital. Eighty-six patients were randomized into intervention (n = 43) and control (n = 43) groups. Adherence and quality of life were measured using the Medication Adherence Rating Scale (MARS) and EQ-5D-5L, respectively. After one month, the intervention group demonstrated significantly higher adherence (97.7% vs. 79.0%, p < 0.001) and improvement in mean MARS scores (24.7 vs. 22.7, p < 0.001). Although quality of life gains were not statistically significant overall, notable improvements were observed in anxiety/depression and self-care domains. Demographic factors influenced outcomes: patients aged 29–39 and those living with others showed better adherence, while patients aged 40–50 experienced greater quality of life gains. Women aged 51–60 living alone had decreased adherence despite quality of life improvements. These results suggest that mHealth tools like TB-R can enhance adherence, especially when supported by favorable social and demographic conditions. Tailored digital interventions may optimize treatment outcomes in TB care. Future mHealth app development should consider these social and demographic factors to maximize effectiveness and user engagement.
Cost-Effectiveness of Oseltamivir and Favipiravir in Covid-19 Patients: a Cost-Effectiveness Analysis Study in a Hospital Yusransyah, Yusransyah; S.farm, Baha Udin
JSFK (Jurnal Sains Farmasi & Klinis) Vol 12 No 1 (2025): J Sains Farm Klin 12(1), April 2025
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.12.1.29-35.2025

Abstract

The COVID-19 pandemic poses not only a threat to health but also to the global economy, including healthcare costs. Although there is no specific drug for COVID-19 patients, there are antiviral drugs such as oseltamivir and favipiravir that can be used to treat COVID-19. The purpose of this study was to determine the most cost-effective antiviral therapy between oseltamivir and favipiravir for COVID-19 patients in one of the hospitals in Banten province. The pharmacoeconomic method used in this study was cost-effectiveness analysis by calculating the Average Cost-Effectiveness Ratio (ACER) and Incremental Cost-Effectiveness Ratio (ICER). The results of this study showed that the ACER value of the favipiravir group (IDR  364,010 (n = 7)) was lower than the oseltamivir group (IDR 431,744 (n = 7)), with an ICER value of IDR  60,605. Based on the results of the Mann-Whitney test, there was no significant difference between the costs of the favipiravir and oseltamivir groups (p value 0.940). The sensitivity test showed that the cost of medical consumables was the cost that had the greatest impact on cost-effectiveness. Based on the calculation results, it can be concluded that the favipiravir group is more cost-effective than the oseltamivir group.
Pharmacoeconomic Analysis of Drugs Used in Chronic Outpatients at Berkah Pandeglang Regional Hospital Yusransyah, Yusransyah; Nurhikmah, Ihda; Maharani, Zahra Citra; Stiani, Sofi Nurmay; Shobah, Afifah Nur; Udin, Baha
Sciences of Pharmacy Volume 4 Issue 3
Publisher : ETFLIN Publishing House

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0403343

Abstract

Hypertension and type 2 diabetes mellitus (T2DM) are chronic conditions requiring long-term pharmacotherapy, placing significant financial pressure on patients and healthcare systems. Drug selection should prioritize both clinical efficacy and cost-efficiency, particularly in resource-limited settings. This study conducted a pharmacoeconomic evaluation of commonly used therapies at RSUD Berkah Pandeglang using a retrospective, non-experimental design. Data were collected from 2023 outpatient records and analyzed from the hospital’s perspective. Cost-effectiveness was assessed using the Average Cost-Effectiveness Ratio (ACER). For hypertension, amlodipine (n=20) had a lower ACER (Rp 283,913) than candesartan (n=15; Rp 883,000), indicating higher cost-effectiveness. In T2DM patients, metformin (n=25) was more cost-effective (ACER: Rp 317,746.75) than glimepiride (n=25; ACER: Rp 607,148.84). These findings support prioritizing amlodipine and metformin as first-line treatments in similar public healthcare settings to improve therapeutic outcomes while managing costs.
Analisis biaya penggunaan analgetik sebagai terapi antinyeri pada pasien pasca bedah apendisitis di RSUD Aulia Pandeglang Yusransyah, Yusransyah; Stiani, Sofi Nurmay; Cahya, Wulan; Udin, Baha
Journal of Holistic and Health Sciences (Jurnal Ilmu Holistik dan Kesehatan) Vol. 9 No. 1 (2025): Journal of Holistic and Health Sciences (Jurnal Ilmu Holistik dan Kesehatan)
Publisher : Sekolah Tinggi Ilmu Kesehatan Holistik

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51873/jhhs.v9i1.349

Abstract

Latar belakang: Penggunaan analgetik sebagai terapi antinyeri pada pasien pasca bedah apendisitis di rumah sakit memiliki peran yang signifikan dalam mendukung proses pemulihan pasien. Namun, seiring meningkatnya biaya perawatan kesehatan, penting bagi fasilitas kesehatan untuk mengoptimalkan penggunaan analgetik agar tetap efektif namun juga ekonomis. Minimisasi biaya penggunaan analgetik tanpa mengorbankan efektivitas terapi menjadi tantangan utama dalam memastikan pasien mendapatkan perawatan yang optimal. Tujuan penelitian: Penelitian ini bertujuan untuk menentukan penggunaan obat analgesik dengan biaya paling rendah pada pasien pasca operasi apendisitis di RSUD Aulia Pandeglang. Metode penelitian: Metode penelitian yang digunakan adalah pengambilan data secara retrospektif dengan menggunakan data sekunder berupa rekam medis dan rincian biaya pengobatan pasien pasca operasi apendisitis yang tersedia di rumah sakit. Hasil: Hasil penelitian menunjukkan bahwa rata-rata biaya total untuk analgetik Tramadol injeksi dengan lama pengobatan 3 hari adalah Rp. 2.893.400,00/pasien, Dexketoprofen oral dengan lama pengobatan 3 hari adalah Rp. 11.051.400,00/pasien, Ketorolac injeksi dengan lama pengobatan 9 hari adalah Rp. 27.067.531,00/pasien, Paracetamol oral dengan lama pengobatan 7 hari adalah Rp. 13.212.000,00/pasien, Asam Mefenamat oral dengan lama pengobatan 10 hari adalah Rp. 2.929.000,00/pasien, Natrium Diklofenak oral dengan lama pengobatan 3 hari adalah Rp. 10.929.052,00/pasien, Ibuprofen oral dengan lama pengobatan 5 hari adalah Rp. 3.957.000,00/pasien, dan Ketoprofen injeksi dengan lama pengobatan 6 hari adalah Rp. 13.239.000,00/pasien. Simpulan: Berdasarkan data tersebut, analgetik injeksi Tramadol memiliki biaya total rata-rata paling rendah dibandingkan dengan analgetik lainnya
Co-Authors Abdillah , Mursyid Abdillah Mursyid Ade Anwar Adini, Syilvi Aditia Saeffurrohman Afifah Nur Shobah Ahmad Sofan Ai Yeni Herlinawati Alfarizqi, Asep Salman Andri Harpan Anita Nugraheni, Diesty Anjani, Shabrina Talitha Ashari, Elva Febri Aulia, Ayu Ayuni, Eka Sirly Baha Udin Bahaudin Bahaudin Bahaudin Bahaudin, Bahaudin Banu Kuncoro Cahya, Wulan Chairani, Farahdina Dewi Intan Sri Rahayu Diesty Anita Nugraheni Dina Pratiwi S.farm, M.Sc Effendi, Erwin Endah Endah endah, endah Endang Safitri Eneng Elda Ernawati Epinur , Ernawati, Eneng Elda Eva Kholifah Fahlevy, Muhamad Ichsan Fajrin Noviyanto Fajrin Noviyanto, Fajrin Farahdina Chairani Farahdina, Chairani Fathiyati Fathiyati Fauzi, Andrian Maulana Ferdiyansyah, Ferdiyansyah Fifih Lutfiyah Hadi Susilo Hakim, Imam Lukmanul Hanifah Dwi Safitri Harpan, Andri Hasanah, Indah Ayu Nur Herawati, Fera Imam Lukmanul Hakim Imas Masfuah Indriatmoko, Dimas Danang Ismiyati, Renditya Jovita Almira Junaedi, Candra Kelutur, Faruk Jayanto Kholifah, Eva Kuncoro, Banu Kurnia, Nia Marlina Latif , Yudha Aditama Latif Yudha Aditama Latifah Nur, Rizki Leni Halimatusyadiah Lia Khaerunnisa Lukmanul Hakim, Imam Lydya Elfira Sari Nasution Maharani, Sylvianti Maharani, Zahra Citra Marlina, Nia Masfuah, Imas Meila Pertiwi Mohammad Rizal Mohammad Rizal, Mohammad Muhammad Nurmiftahuddin Mulyani, Yani Mulyani Murdianto, Yudi Mursyid, Abdillah Nabillah, Deya Adiby Nana Suryana Nasiti, Febriane Dwi Nia Marlina Nur Insani Nur Shobah, Afifah Nuraini M.Farm, Apt Nurani, Agnes Wieanita Nurhayati, Ghina Siti Nurhikmah, Ihda Nuriyatul Fhatonah Nurul Fitri, Nabila Nurul Insani Ofsah, Olin Najilah Oktaviana Hadi, Agriyaningsih Perdi, Perdi Pratiwi, Linda Rani Pratiwi, Rossi Pujiati, Devi Putri, Nabila Septiani Rahmawida Putri Rahmawida Putri Raiyan Renditya Ismiyati Renditya Ismiyati Reza Sudrajat Ristiani, Yuanisa Rizki Robul Izati Rizkiana, Muhammad Dinta Rozwaliza Annintan Rustiyani, Risa Sabilla, Aliffia Nur Saeffurrohman, Aditia Saepudin Saepudin Salsabillah, Audy Nursifa'atun Seira, Trisya Selviani, Astri Septina Sumantri, Aulia Setiawan, Abdul Aziz Shabrina Talitha Anjani Shirly Kumala Shobah, Afifah Nur Siswa Setyahadi Siti Hodijah Siti Lailatu Zahroh Siti Rhopi’ah Soraya Uli, Elisabeth Stiani, Sofi Nurmay Subchan, Mohamad Sudarto, Teguh Sumarlin US Syifa Maulidia Rizqi Syilvi Adini Sylvi Addini Sylvianti Maharani Tuty Sriwahyuni US, Sumarlin Wibirezkina, Aufalya Yulistina, Isti Yuni Rahmawati Yuningsih Yuningsih Zulfiani, Nia